Comments: Senate TROA Sponsors Urge CMS to Update Obesity Treatment Regulations

To the Honorable Seema Verma

Administrator, Centers for Medicare & Medicaid Services

As the primary sponsors of S. 595, the Treat and Reduce Obesity Act (TROA), we write to urge you to update your regulations for coverage of obesity treatments, including Food & Drug Administration (FDA) approved anti-obesity agents (AOMs). and Intensive Behavioral Therapy (IBT). We are hopeful that CMS will recognize the tremendous impact that COVID-19 is having on the health outcomes of so many Americans affected by obesity and that the agency moves swiftly to update Medicare’s coverage policies to support comprehensive treatment of obesity to better protect seniors from this deadly pandemic.